Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Ascendis Pharma A/S ADR
ASND
$
163.35
-0.4%
Fri October 16th, 2020
18:03
Analysis
Pounding The Table For Undervalued OPKO Health
Seeking Alpha
Tue September 29th, 2020
15:04
Analysis
Ascendis Progresses With Hypoparathyroidism Drug TransCon PTH
Zacks
Fri August 28th, 2020
03:48
Earnings
Analysis
Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
02:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript
The Motley Fool
+ 1 more
Thu August 13th, 2020
16:48
Analysis
Ascendis' Dwarfism Candidate Gets Orphan Drug Status in EU
Zacks
Tue June 30th, 2020
07:45
Analysis
Alexion's European Approval And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Mon June 29th, 2020
15:44
Analysis
Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD
Zacks
